These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36448239)
1. Diagnostic and prognostic values of MMP-9 expression in ovarian cancer: A study based on bioinformatics analysis and meta-analysis. Liu C; Shen Y; Tan Q Int J Biol Markers; 2023 Mar; 38(1):15-24. PubMed ID: 36448239 [TBL] [Abstract][Full Text] [Related]
2. MMP-16 as a New Biomarker for Predicting Prognosis and Chemosensitivity of Serous Ovarian Cancer: A Study Based on Bioinformatics Analysis. Wang W; Liu Y; Yang Y; Huang X; Hou Y Crit Rev Eukaryot Gene Expr; 2021; 31(4):1-8. PubMed ID: 34587431 [TBL] [Abstract][Full Text] [Related]
3. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis. Liu C Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Li LN; Zhou X; Gu Y; Yan J Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961 [TBL] [Abstract][Full Text] [Related]
5. The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer. Fu Z; Xu S; Xu Y; Ma J; Li J; Xu P Int J Gynecol Cancer; 2015 Mar; 25(3):356-62. PubMed ID: 25695542 [TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study. Wang L J Ovarian Res; 2019 Apr; 12(1):37. PubMed ID: 31039792 [TBL] [Abstract][Full Text] [Related]
7. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis. Cui Y; Hong S; Zhu X Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining. Li XJ; Pang JS; Li YM; Ahmed FA; He RQ; Ma J; Ma FC; Chen G Pathol Res Pract; 2018 Mar; 214(3):385-401. PubMed ID: 29499854 [TBL] [Abstract][Full Text] [Related]
9. Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis. Trudel D; Desmeules P; Turcotte S; Plante M; Grégoire J; Renaud MC; Orain M; Bairati I; Têtu B Mod Pathol; 2014 Oct; 27(10):1394-404. PubMed ID: 24603589 [TBL] [Abstract][Full Text] [Related]
10. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data. Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion. Hu X; Li D; Zhang W; Zhou J; Tang B; Li L Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis. Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Huang QT; Zhou L; Zeng WJ; Ma QQ; Wang W; Zhong M; Yu YH Cell Physiol Biochem; 2017; 41(6):2411-2418. PubMed ID: 28467978 [TBL] [Abstract][Full Text] [Related]
14. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers. Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis. Desmeules P; Trudel D; Turcotte S; Sirois J; Plante M; Grégoire J; Renaud MC; Orain M; Têtu B; Bairati I Hum Pathol; 2015 May; 46(5):739-45. PubMed ID: 25771900 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Matrix Metalloproteinase 14 in Patients with Cancer: a Systematic Review and Meta-Analysis. Zhang L; Jin S; Wei Y; Wang C; Zou H; Hu J; Jia W; Pang L Clin Lab; 2020 May; 66(5):. PubMed ID: 32390382 [TBL] [Abstract][Full Text] [Related]
17. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer. Vos MC; van der Wurff AA; Bulten J; Kruitwagen R; Feijen H; van Kuppevelt TH; Hendriks T; Massuger LF Diagn Pathol; 2016 Apr; 11():34. PubMed ID: 27038607 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of serum miR-21 in patients with ovarian cancer: a systematic review and meta-analysis. Qiu L; Weng G J Ovarian Res; 2022 May; 15(1):51. PubMed ID: 35501921 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis. Song J; Su H; Zhou YY; Guo LL Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis. Jia H; Zhang Q; Liu F; Zhou D Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]